2. Role of ascorbic acid & statin in reduction of the incidence of the atrial fibrillation in patients under B-blocker and undergoing coronary artery bypass graft operation in early post-operative period
Atrial fibrillation (AF) is the most common sustained arrhythmia that is associated with significant morbidity and mortality. Current available therapies remain inadequate in symptom control and secondary prevention and are often associated with significant side effects. The mechanisms underlying th...
Main Authors: | Hazem Bakr, Tarek Elsayegh, Mohamed Abd El Fatah |
---|---|
Format: | Article |
Language: | English |
Published: |
Saudi Heart Association
2015-10-01
|
Series: | Journal of the Saudi Heart Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1016731515002420 |
Similar Items
-
Atrial fibrillation post cardiac bypass surgery
by: Ashraf Mostafa, et al.
Published: (2012-07-01) -
Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01) -
Does Off-pump Coronary Artery Bypass Reduce the Prevalence of Atrial Fibrillation?
by: Khosrow Hashemzadeh, et al.
Published: (2013-07-01) -
Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects
by: Homa Nomani, et al.
Published: (2021-02-01) -
Factors influencing postoperative atrial fibrillation in patients undergoing on-pump coronary artery bypass grafting, single center experience
by: Mohamed F. Ismail, et al.
Published: (2017-05-01)